A new weight loss pill, Ozempic boosts protein sales, J&J's cancer drug: Pharma news roundupByBruce GilPublishedJuly 19, 2024
The TV networks and streamers that got the most Emmy nominations — and the leastByBruce GilUpdatedJuly 18, 2024
A new weight loss pill has Novo Nordisk and Eli Lilly shares fallingByBruce GilPublishedJuly 17, 2024
Johnson & Johnson's cancer drug Darzalex could replace Stelara as its best-sellerByBruce GilUpdatedJuly 17, 2024
Warner Bros. Discovery 'is not working' and should make some big changes, analysts sayByBruce GilPublishedJuly 16, 2024
Netflix reports earnings this week. Here's what analysts are watchingByBruce GilPublishedJuly 16, 2024
The next big thing in the weight loss drug boom has little to do with losing weightByBruce GilPublishedJuly 15, 2024
Getting sick on a cruise ship could cost you as much as the vacationByBruce GilPublishedJuly 14, 2024
Millennials and weight loss drugs are fueling customers' growing obsession with proteinByBruce GilPublishedJuly 12, 2024
Ozempic and other weight loss drugs pose new risks for surgery, Europe warnsByBruce GilPublishedJuly 12, 2024
Pfizer's weight loss pill, Novo Nordisk's setback, and the FTC vs. drug middlemen: Pharma news roundupByBruce GilUpdatedJuly 12, 2024
Novo Nordisk's once-weekly insulin is rejected by the FDA, in latest set back for the pharma giantByBruce GilPublishedJuly 11, 2024
A contaminated cooking oil scandal in China has set off a major government probeByBruce GilPublishedJuly 11, 2024
Pfizer says it is advancing development of a once-daily weight loss pillByBruce GilPublishedJuly 11, 2024
